Warfarin glycosylation invokes a switch from anticoagulant to anticancer activity.

Warfarin glycosylation invokes a switch from anticoagulant to anticancer activity.

ChemMedChem (2011-06-30)

Pauline Peltier-Pain, Shannon C Timmons, Agnès Grandemange, Etienne Benoit, Jon S Thorson

MATERIALS

Product Number

Brand

Product Description

Sigma-Aldrich

2-Deoxy-L-ribose, ≥97.0% (TLC)